Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents

Neuropsychopharmacology

Volumn 34, Issue 13, 2009, Pages 2721-2732

  Rao, Uma ^a   Hammen, Constance L ^b   London, Edythe D ^b,c   Poland, Russell E ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Adolescents; Depression; HPA axis; Smoking; Stress; Vulnerability

Indexed keywords

HYDROCORTISONE;

ADOLESCENT; AFRICAN AMERICAN; ANXIETY DISORDER; ARTICLE; ASIAN AMERICAN; BECK DEPRESSION INVENTORY; CAUCASIAN; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DISEASE EXACERBATION; DISRUPTIVE BEHAVIOR; ENVIRONMENTAL STRESS; ETHNICITY; FAMILY HISTORY; FEMALE; FOLLOW UP; HAMILTON SCALE; HIGH RISK PATIENT; HISPANIC; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; SALIVA ANALYSIS; SOCIAL STATUS;

ADOLESCENT; ADOLESCENT BEHAVIOR; DEPRESSIVE DISORDER, MAJOR; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RISK FACTORS; SALIVA; SMOKING; STRESS, PSYCHOLOGICAL;

EID: 70449526170     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.112     Document Type: Article

References (136)

1. Al'Absi M (2006). Hypothalamic-pituitary-adrenocortical responses to psychological stress and risk for smoking relapse. Int J Psychophysiol 59: 218-227.
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press: Washington, DC.
3. Anda RF, Croft JB, Felitti VJ, Nordenberg D, Giles WH, Williamson DF et al (1999). Adverse childhood experiences and smoking during adolescence and adulthood. JAMA 282: 1652-1658.
4. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL (1990). Depression and the dynamics of smoking. A national perspective. JAMA 264: 1541-1545.
5. Andreasen NC, Endicott J, Spitzer RL, Winokur G (1977). The family history method using diagnostic criteria. Reliability and validity. Arch Gen Psychiatry 34: 1229-1235.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
7. Berlin I (2009). Endocrine and metabolic effects of smoking cessation. Curr Med Res Opin 25: 527-534.
8. Berlin I, Spreux-Varoquaux O, Said S, Launay JM (1997). Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and-B activities and withdrawal symptoms in dependent smokers. Drug Alcohol Depend 45: 31-37.
9. Borrelli B, Niaura R, Keuthen NJ, Goldstein MG, DePue JD, Murphy C et al (1996). Development of major depressive disorder during smoking-cessation treatment. J Clin Psychiatry 57: 534-538.
10. Botello-Harbaum MT, Haynie DL, Iannotti RJ, Wang J, Gase L, Simons-Morton B (2009). Tobacco control policy and adolescent cigarette smoking status in the United States. Nicotine Tobacco Res 11: 875-885.
11. Brenner T, Mizrachi R, Bodoff M, Weidenfeld J (1986). Evidence that central nicotinic-acetylcholine receptors are involved in the modulation of basal and stress-induced adrenocortical responses. Exp Neurol 94: 735-743.
12. Breslau N, Johnson EO (2000). Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health 90: 1122-1127.
13. Breslau N, Kilbey M, Andreski P (1991). Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry 48: 1069-1074.
14. Breslau N, Kilbey MM, Andreski P (1992). Nicotine withdrawal symptoms and psychiatric disorders: findings from an epide-miologic study of young adults. Am J Psychiatry 149: 464-469.
15. Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P (1998). Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiatry 55: 161-166.
16. Brown GW, Harris T (1978). Social Origins of Depression. Tavistock: London.
17. Brown RA, Lewinsohn PM, Seeley JR, Wagner EF (1996). Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J Am Acad Child Adolesc Psychiatry 35: 1602-1610.
18. Bruijnzeel AW, Gold MS (2005). The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence. Brain Res Brain Res Rev 49: 505-528.
19. Bruijnzeel AW, Zislis G, Wilson C, Gold MS (2007). Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 32: 955-963.
20. Byrne DG, Byrne AE, Reinhart MI (1995). Personality, stress and the decision to commence cigarette smoking in adolescence. J Psychosom Res 39: 53-62.
21. Byrne DG, Mazanov J (2003). Adolescent stress and future smoking behaviour: a prospective investigation. J Psychosom Res 54: 313-321.
22. Caggiula AR, Donny EC, Epstein LH, Sved AF, Knopf S, Rose C et al (1998). The role of corticosteroids in nicotine0s physiological and behavioral effects. Psychoneuroendocrinology 23: 143-159.
23. Caraballo RS, Giovino GA, Pechacek TF (2004). Self-reported cigarette smoking vs serum cotinine among US adolescents. Nicotine Tob Res 6: 19-25.
24. Caraballo RS, Novak SP, Asman K (2009). Linking quantity and frequency profiles of cigarette smoking to the presence of nicotine dependence symptoms among adolescent smokers: findings from the 2004 National Youth Tobacco Survey. Nicotine Tob Res 11: 49-57.
25. Centers for Disease Control and Prevention (2002). Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Morb Mortal Wkly Rep 51: 300-303.
26. Centers for Disease Control and Prevention (2006). Youth Risk Behavior Surveillance-United States. MMWR Morb Mortal Wkly Rep 55(SS-5): 1108.
27. Chen H, Fu Y, Sharp BM (2008). Chronic nicotine self-administration augments hypothalamic-pituitary-adrenal responses to mild acute stress. Neuropsychopharmacology 33: 721-730.
28. Choi WS, Patten CA, Gillin JC, Kaplan RM, Pierce JP (1997). Cigarette smoking predicts development of depressive symptoms among US adolescents. Ann Behav Med 19: 42-50.
29. Cohen S, Lichtenstein E (1990). Perceived stress, quitting smoking, and smoking relapse. Health Psychol 9: 466-478.
30. Colby SM, Tiffany ST, Shiffman S, Niaura RS (2000). Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend 59(Suppl 1): S83-S95.
31. Covey LS, Glassman AH, Stetner F (1990). Depression and depressive symptoms in smoking cessation. Compr Psychiatry 31: 350-354. (Pubitemid 20333849)
32. Covey LS, Glassman AH, Stetner F (1997). Major depression following smoking cessation. Am J Psychiatry 154: 263-265.
33. Dahl RE, Ryan ND, Puig-Antich J, Nguyen NA, al-Shabbout M, Meyer VA et al (1991). 24-hour cortisol measures in adolescents with major depression: a controlled study. Biol Psychiatry 30: 25-36.
34. Davies GE, Soundy TJ (2009). The genetics of smoking and nicotine addiction. S D Med Spec No: 43-49.
35. Dozois DN, Farrow JA, Miser A (1995). Smoking patterns and cessation motivations during adolescence. Int J Addict 30: 1485-1498.
36. Duman RS, Malberg J, Thome J (1999). Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46: 1181-1191.
37. Dursun SM, Kutcher S (1999). Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research. Med Hypotheses 52: 101-109.
38. Fagerström KO (1978). Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3: 235-241.
39. Fahlke C, Hard E, Thomasson R, Engel JA, Hansen S (1994). Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats. Pharmacol Biochem Behav 48: 977-981.
40. Fergusson DM, Goodwin RD, Horwood LJ (2003). Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychol Med 33: 1357-1367.
41. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW et al (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48: 851-855.
42. Frederick SL, Reus VI, Ginsberg D, Hall SM, Munoz RF, Ellman G (1998). Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol Psychiatry 43: 525-530.
43. Friedman AJ, Ravnikar VA, Barbieri RL (1987). Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril 47: 398-401.
44. Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, Mackin P (2008). Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev 23: CD005168.
45. Gamberino WC, Gold MS (1999). Neurobiology of tobacco smoking and other addictive disorders. Psychiatr Clin North Am 22: 301-312.
46. Ginsberg D, Hall SM, Reus VI, Muñoz RF (1995). Mood and depression diagnosis in smoking cessation. Exp Clin Psycho-pharmacol 3: 389-395.
47. Glassman AH, Covey LS, Stetner F, Rivelli S (2001). Smoking cessation and the course of major depression: a follow-up study. Lancet 357: 1929-1932.
48. Goodman E, Capitman J (2000). Depressive symptoms and cigarette smoking among teens. Pediatrics 106: 748-755.
49. Goodyer IM, Park RJ, Herbert J (2001). Psychosocial and endocrine features of chronic first-episode major depression in 8-16 year olds. Biol Psychiatry 50: 351-357.
50. Goodyer IM, Herbert J, Altham PME (1997). Short-term outcome of major depression: III. A high cortisol/DHEA ratio and subsequent disappointing life events predict persistent depression. Psychol Med 28: 265-273.
51. Hajek P, Stead LF, West R, Jarvis M, Lancaster T (2009). Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 21: CD003999.
52. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
53. Hammen C (2005). Stress and depression. Ann Rev Clin Psychol 1: 293-319.
54. Hammen C, Brennan PA (2001). Depressed adolescents of depressed and nondepressed mothers: tests of an interpersonal impairment hypothesis. J Consult Clin Psychol 69: 284-294.
55. Hammen CL, Burge D, Daley SE, Davila J, Paley B, Rudolph KD (1995). Interpersonal attachment cognitions and prediction of symptomatic responses to interpersonal stress. J Abnorm Psychol 104: 436-443.
56. Holsboer F (2001). Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord 62: 77-91.
57. Holsboer F, Ising M (2008). Central CRH system in depression and anxiety-evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583: 350-357.
58. John U, Meyer C, Rumpf HJ, Hapke U (2004). Depressive disorders are related to nicotine dependence in the population but do not necessarily hamper smoking cessation. J Clin Psychiatry 65: 169-176.
59. Johnson JG, Cohen P, Pine DS, Klein DF, Kasen S, Brook JS (2000). Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA 284: 2348-2351. (Pubitemid 30828679)
60. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE (2009). Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2008 (NIH Publication No. 09-7401). National Institute on Drug Abuse: Bethesda, MD.
61. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36: 980-988.
62. Kaufman J, Birmaher B, Brent D, Rao U, Ryan ND (1996). The Schedule for Affective Disorders and Schizophrenia for School-aged Children-Present and Lifetime Versions (K-SADS-PL). Western Psychiatric Institute and Clinics, University of Pittsburgh: Pittsburgh, PA.
63. Kaufman J, Martin A, King RA, Charney D (2001). Are child-, adolescent-, and adult-onset depression one and the same disorder? Biol Psychiatry 49: 9801001.
64. Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, Heath AC et al (1995). Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 152: 833-842.
65. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC (1993). Smoking and major depression. A causal analysis. Arch Gen Psychiatry 50: 36-43.
66. Khaled SM, Bulloch A, Exner DV, Patten SB (2009). Cigarette smoking, stages of change, and major depression in the Canadian population. Can J Psychiatry 54: 204-208.
67. Klungs0yr O, Nygard JF, Sorensen T, Sandanger I (2006). Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. AmJEpidemiol 163: 421-432.
68. Koob G, Kreek MJ (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164: 1149-1159.
69. Koval JJ, Pederson LL, Mills CA, McGrady GA, Carvajal SC (2000). Models of the relationship of stress, depression, and other psychosocial factors to smoking behavior: a comparison of a cohort of students in grades 6 and 8. Prev Med 30: 463-477.
70. Kudielka BM, Hellhammer DH, Wust S (2009). Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology 34: 218.
71. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006). The Global Burden of Disease and Risk Factors. The International Bank for Reconstruction and Development/The World Bank & New York: Oxford University Press, Washington, DC.
72. Lovallo WR (2006). Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiol 59: 195-202.
73. Markou A (2008). Review. Neurobiology of nicotine dependence. Philos Trans R Soc Lond B Biol Sci 363: 3159-3168.
74. Markou A, Kosten TR, Koob GF (1998). Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18: 135-174.
75. Matta SG, Fu Y, Valentine JD, Sharp BM (1998). Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroen-docrinology 23: 103-113.
76. Max W (2001). The financial impact of smoking on health-related costs: a review of the literature. Am J Health Promot 15: 321-331.
77. Mayhew KP, Flay BR, Mott JA (2000). Stages in the development of adolescent smoking. Drug Alcohol Depend 59(Suppl 1): S61-S81.
78. McCarthy DE, Piasecki TM, Fiore MC, Baker TB (2006). Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol 115: 454-466.
79. McCracken JT, Poland RE (1989). Saliva and serum cortisol dynamics following intravenous dexamethasone in normal volunteers. Life Sci 45: 1781-1785.
80. Mendelson JH, Goletiani N, Sholar MB, Siegel AJ, Mello NK (2008). Effects of smoking successive low-and high-nicotine cigarettes on hypothalamic- pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology 33: 749-760.
81. Meyer SE, Chrousos GP, Gold PW (2001). Major depression and the stress system: a life span perspective. Dev Psychopathol 13: 565-580.
82. Moolchan ET, Ernst M, Henningfield JE (2000). A review of tobacco smoking in adolescents: treatment implications. J Am Acad Child Adolesc Psychiatry 39: 682-693.
83. Munafò MR, Hitsman B, Rende R, Metcalfe C, Niaura R (2008). Effects of progression to cigarette smoking on depressed mood in adolescents: evidence from the National Longitudinal Study of Adolescent Health. Addiction 103: 162-171.
84. Nichter M, Vuckovic N, Quintero G, Ritenbaugh C (1997). Smoking experimentation and initiation among adolescent girls: qualitative and quantitative findings. Tob Control 6: 285-295.
85. Nilsson KW, Oreland L, Kronstrand R, Leppert J (2009). Smoking as a product of gene-environment interaction. Ups J Med Sci 114: 100-107.
86. O'Dell LE, Khroyan TV (2009). Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans? Pharmacol Biochem Behav 91: 481-488.
87. O'Loughlin J, DiFranza J, Tyndale RF, Meshefedjian G, McMillan-Davey E, Clarke PB et al (2003). Nicotine-dependence symptoms are associated with smoking frequency in adolescents. Am J Prev Med 25: 219-225.
88. Orlando M, Ellickson PL, Jinnett K (2001). The temporal relationship between emotional distress and cigarette smoking during adolescence and young adulthood. J Consult Clin Psychol 69: 959-970.
89. Pallonen UE, Prochaska JO, Velicer WF, Prokhorov AV, Smith NF (1998). Stages of acquisition and cessation for adolescent smoking: an empirical integration. Addict Behav 23: 303-324.
90. Park ER, Chang Y, Quinn V, Regan S, Cohen L, Viguera A et al (2009). The association of depressive, anxiety, and stress symptoms and postpartum relapse to smoking: a longitudinal study. Nicotine Tob Res 11: 707-714.
91. Parrott AC (1995). Stress modulation over the day in cigarette smokers. Addiction 90: 233-244.
92. Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert M, Bowes G (1998). Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health 88: 1518-1522.
93. Pauly JR, Grun EU, Collins AC (1990a). Chronic corticosterone administration modulates nicotine sensitivity and brain nico-tinic receptor binding in C3H mice. Psychopharmacology (Berl) 101: 310-316.
94. Pauly JR, Ullman EA, Collins AC (1990b). Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse. Pharmacol Biochem Behav 35: 171-179.
95. Paykel E, Mangen S (1980). Interview for Recent Life Events. St George's Hospital Medical School. Department of Psychiatry: London.
96. Perkins KA, Grobe JE (1992). Increased desire to smoke during acute stress. Br J Addict 87: 1037-1040.
97. Piazza PV, Deminiere JM, Le Moal M, Simon H (1989). Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511-1513.
98. Piazza PV, Marinelli M, Jodogne C, Deroche V, Rouge-Pont F, Maccari S et al (1994). Inhibition of corticosterone synthesis by Metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res 658: 259-264.
99. Poland RE, Rubin RT (1982). Saliva cortisol levels following dexamethasone administration in endogenously depressed patients. Life Sci 30: 177-181.
100. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS (1995). Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 7: 373-378.
101. Pomerleau OF, Pomerleau CS (1990). Cortisol response to a psychological stressor and/or nicotine. Pharmacol Biochem Behav 36: 211-213.
102. Prokhorov AV, De Moor C, Pallonen UE, Hudmon KS, Koehly L, Hu S (2000). Validation of the modified Fagerstrom tolerance questionnaire with salivary cotinine among adolescents. Addict Behav 25: 429-433.
103. Prokhorov AV, Hudmon KS, de Moor CA, Kelder SH, Conroy JL, Ordway N (2001). Nicotine dependence, withdrawal symptoms, and adolescents readiness to quit smoking. Nicotine Tob Res 3: 151-155.
104. Prokhorov AV, Pallonen UE, Fava JL, Ding L, Niaura R (1996). Measuring nicotine dependence among high-risk adolescent smokers. Addict Behav 21: 117-127.
105. Rao U, Chen LA (2008). Neurobiological and psychosocial processes associated with depressive and substance-related disorders in adolescents. Current Drug Abuse Rev 1: 68-80.
106. Rao U, Chen LA (2009). Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders. Dialogues Clin Neurosci 11: 45-62.
107. Rao U, Dahl RE, Ryan ND, Birmaher B, Williamson DE, Giles DE et al (1996). The relationship between longitudinal clinical course and sleep and cortisol changes in adolescent depression. Biol Psychiatry 40: 474-484.
108. Rao U, Daley SE, Hammen C (2000). Relationship between depression and substance use disorders in adolescent women during the transition to adulthood. J Am Acad Child Adolesc Psychiatry 39: 215-222.
109. Rao U, Hammen C, Ortiz LR, Chen LA, Poland RE (2008). Effects of early and recent adverse experiences on adrenal response to psychosocial stress in depressed adolescents. Biol Psychiatry 64: 521-526.
110. Rao U, Hammen CL, Poland RE (2009a). Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: interactions between stress and HPA activity. Am J Psychiatry 166: 361-369.
111. Rao U, Hammen CL, Poland RE (2009b). Risk markers for depression in adolescents: sleep and HPA measures. Neuropsy-chopharmacology 34: 1936-1945.
112. Rao U, Ott GE, Lin KM, Gertsik L, Poland RE (2005). Effect of bupropion on nocturnal urinary free cortisol and its association with antidepressant response. J Psychiatr Res 39: 183-190.
113. Rao U, Ryan ND, Dahl RE, Birmaher B, Rao R, Williamson DE et al (1999). Factors associated with the development of substance use disorder in depressed adolescents. J Am Acad Child Adolesc Psychiatry 38: 1109-1117.
114. Rasmusson AM, Wu R, Paliwal P, Anderson GM, Krishna-Sarin S (2006). A decrease in the plasma DHEA to cortisol ratio during smoking abstinence may predict relapse: a preliminary study. Psychopharmacology 186: 473-480.
115. Riggs PD, Mikulich SK, Whitmore EA, Crowley TJ (1999). Relationship of ADHD, depression, and non-tobacco substance use disorders to nicotine dependence in substance-dependent delinquents. Drug Alcohol Depend 54: 195-205.
116. Rohleder N, Kirschbaum C (2006). The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. Int J Psychophysiol 59: 236-243.
117. Rubinstein ML, Thompson PJ, Benowitz NL, Shiffman S, Moscicki AB (2007). Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers. Nicotine Tob Res 9: 129-135.
118. Sarnyai Z, Dhabhar FS, McEwen BS, Kreek MJ (1998). Neuroendo-crine- related effects of long-term, 'binge' cocaine administration: diminished individual differences in stress-induced corticoster-one response. Neuroendocrinology 68: 334-344.
119. Schepis TS, Rao U (2005). Epidemiology and etiology of adolescent smoking. Curr Opin Pediatr 17: 607-612.
120. Schepis TS, Rao U (2008). Smoking cessation for adolescents: a review of pharmacological and psychosocial treatments. Current Drug Abuse Rev 1: 142-154.
121. Seymour PA, Schmidt AW, Schulz DW (2003). The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review. CNS Drug Rev 9: 57-96.
122. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H et al (1983). A children's global assessment scale (CGAS). Arch Gen Psychiatry 40: 1228-1231.
123. Shapiro D, Jamner LD, Davydov DM, James P (2002). Situations and moods associated with smoking in everyday life. Psychol Addict Behav 16: 342-345.
124. Shapiro R, Keller M (1979). Longitudinal Interval Follow-Up Evaluation (LIFE). Massachusetts General Hospital: Boston.
125. Shapiro SS, Wilk MB (1965). An analysis of variance test for normality (complete samples). Biometrika 52: 591-611.
126. Sidhartha T, Poland RE, Rao U (2009). Effects of smoking on hormones, brain, and behavior. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT (eds). Hormones, Brain and Behavior 2nd edn, Vol 5. Academic Press: San Diego. pp 3337-9962.
127. Sinha R (2008). Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 1141: 105-130.
128. Siqueira L, Diab M, Bodian C, Rolnitzky L (2000). Adolescents becoming smokers: the roles of stress and coping methods. J Adolesc Health 27: 399-408.
129. Steuber TL, Danner F (2006). Adolescent smoking and depression: which comes first? Addict Behav 31: 133-136.
130. Thompson WD, Orvaschel H, Prusoff BA, Kidd KK (1982). An evaluation of the family history method for ascertaining psychiatric disorders. Arch Gen Psychiatry 39: 53-58.
131. Tonstad S (2002). Use of sustained-release bupropion in specific patient populations for smoking cessation. Drugs 62(Suppl 2): 37-43.
132. Tsoh JY, Humfleet GL, Munoz RF, Reus VI, Hartz DT, Hall SM (2000). Development of major depression after treatment for smoking cessation. Am J Psychiatry 157: 368-374.
133. Volkow ND (2004). The reality of comorbidity: depression and drug abuse. Biol Psychiatry 56: 714-717.
134. Wilkins JN, Carlson HE, Van Vunakis H, Hill MA, Gritz E, Jarvik ME (1982). Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology (Berl) 78: 305-308.
135. Windle M, Windle RC (2001). Depressive symptoms and cigarette smoking among middle adolescents: prospective associations and intrapersonal and interpersonal influences. J Consult Clin Psychol 69: 215-226.
136. Zislis G, Desai TV, Prado M, Shah HP, Bruijnzeel AW (2007). Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology 53: 958-966.